Nervous System Neoplasm — Trials

Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,873 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 601–609 of 609 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05502991	Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNA-level-relapse and Clinical-relapse Glioblastoma	not yet recruiting	Phase 2	60	Henan Provincial People's HospitalOTHER	1	Sep 27, 2022	clinicaltrials
NCT05512351	Sintilimab (One Anti-PD-1 Antibody) Plus Low-dose Bevacizumab for ctDNAlevel- Relapse and Clinical-relapse Oligodendroglioma	recruiting	Phase 2	80	Henan Provincial People's HospitalOTHER	1	Sep 27, 2022